Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents

General and condition-specific essential functions ofPseudomonas aeruginosa

(2015) Samuel A. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

(2015) Adrián Rangel-Vega et al.   Frontiers in Microbiology

Vancomycin protects againstAcinetobacter baumanniiinfection in aGalleria mellonellamodel

(2015) Haifei Yang et al.   Infectious Diseases

Identification of Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors

(2014) Catlyn Blanchard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic – salinomycin

(2014) Michał Antoszczak et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG

(2014) Chathurada Gajadeera et al.   JOURNAL OF ANTIBIOTICS

An Ribonuclease T2 Family Protein Modulates Acinetobacter baumannii Abiotic Surface Colonization

(2014) Anna C. Jacobs et al.   PLoS One

Amplification of Aminoglycoside Resistance Gene aphA1 in Acinetobacter baumannii Results in Tobramycin Therapy Failure

(2014) P. McGann et al.   mBio

Reduced Vancomycin Susceptibility in anIn VitroCatheter-Related Biofilm Model Correlates with Poor Therapeutic Outcomes in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

(2013) Wessam Abdelhady et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Multicenter Case-Case Control Study for Risk Factors and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Bacteremia

(2013) Tat Ming Ng et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data

(2013) Laetitia G. Garcia et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Adenylate Kinase Release as a High-Throughput-Screening-Compatible Reporter of Bacterial Lysis for Identification of Antibacterial Agents

(2012) Anna C. Jacobs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010

(2012) Anne Marie Queenan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

(2012) Dawn M. Sievert et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens

(2012) Kelly C. Fahnoe et al.   PLoS One

In Vivo-Validated Essential Genes Identified in Acinetobacter baumannii by Using Human Ascites Overlap Poorly with Essential Genes Detected on Laboratory Media

(2012) T. C. Umland et al.   mBio

Challenges of Antibacterial Discovery

(2011) L. L. Silver   CLINICAL MICROBIOLOGY REVIEWS

Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant

(2011) D. K. Pomakova et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Characterization of theAcinetobacter baumanniigrowth phase-dependent and serum responsive transcriptomes

(2011) Anna C. Jacobs et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Tackling antibiotic resistance

(2011) Karen Bush et al.   NATURE REVIEWS MICROBIOLOGY

Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis

(2010) A. C. Jacobs et al.   INFECTION AND IMMUNITY

Origins and Evolution of Antibiotic Resistance

(2010) J. Davies et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Acinetobacter baumannii Increases Tolerance to Antibiotics in Response to Monovalent Cations

(2009) M. I. Hood et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotics for Emerging Pathogens

(2009) M. A. Fischbach et al.   SCIENCE

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

(2008) Louis B. Rice   JOURNAL OF INFECTIOUS DISEASES